GW Pharma FQ4 topline down 1%; FY cash flow down 56% - GW Pharmaceuticals plc (NASDAQ:GWPH) | Seeking Alpha: GW Pharmaceuticals (GWPH) fiscal Q4 results ($M): Revenues: 2.4 (-1.2%); product sales: 2.3 (-1.1%). Net loss: (79.9) (-48.2%); loss/share: (0.23) (-27.8%)
explicita
Sem comentários:
Enviar um comentário